论文部分内容阅读
输血治疗是其他治疗无法代替的挽救患者生命的特殊治疗。输血前必须进行交叉配血试验,相合的血液才能输给患者。交叉配血试验必须严格按照试验的方法学进行,确保相合的血液输给患者,防止输血不良反应的发生。但在交叉配血过程中,往往会发生次侧凝集的现象,如果不予以快速、正确的分析处理,将严重影响输血的安全、及时性。微柱凝胶交叉配血是临床输血科中常采用的一种新型免疫分析法,能够有效检出IgM类的抗体以及IgG类的不完全抗体,可有效
Blood transfusions are special treatments that save the lives of patients that other treatments can not replace. Blood transfusion must be cross-matching test before the blood can be lost to patients. Cross-match blood test must be carried out in strict accordance with the test methodologies to ensure that the blood of patients with concomitant loss, to prevent the occurrence of adverse reactions. However, in the process of cross-matching with blood, the phenomenon of secondary agglutination often occurs. If not analyzed quickly and correctly, the safety and timeliness of blood transfusion will be seriously affected. Micro-column gel cross-matching blood is often used in clinical blood transfusion a new immunoassay, can effectively detect IgM antibodies and IgG class antibodies, can be effective